Conrad Wai sold $1.4M of Clover Health Investments, Corp. /De (CLOV) stock

Conrad Wai, CEO, Counterpart Health of Clover Health Investments, Corp. /De (CLOV), sold 300,000 shares of CLOV stock worth $1.4M, per an SEC Form 4 filed Sep 16, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Sep 15, 2026, 1 day before it was made public.

CLOV has moved +0.2% since the trade date, from $4.66 to $4.67 (Sep 22, 2026 close).